General Announcement::Telix Announces Exercise of Optional Redemption Right of Convertible Notes due 2029

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
24-Sep-2026 07:04:18
Status
New
Announcement Sub Title
Telix Announces Exercise of Optional Redemption Right of Convertible Notes due 2029
Announcement Reference
SG260924OTHRHYWL
Submitted By (Co./ Ind. Name)
Ida Lawrance
Designation
Head of Corporate Governance
Effective Date and Time of the event
24/09/2026 17:00:00
Description (Please provide a detailed description of the event in the box below)
Notice that the Issuer will exercise its right to redeem its outstanding convertible notes due 2029 on 29 October 2029.

Attachments